SCHEMBL1347052

SCHEMBL1347052

COc1ccc(Cn2ccnc2C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.70
CYP2D6 P10635 1/20 0.70
CYP2C19 P33261 1/20 0.70
LMNA P02545 1/20 0.55
TDP1 Q9NUW8 1/20 0.54
KMT2A Q03164 1/20 0.53
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
SIGMAR1 Q99720 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
PDE1A P54750 2/20 0.43
PDE1B Q01064 2/20 0.43
PDE1C Q14123 2/20 0.43
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5852468 0.83 CYP1A2 (0.56) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL11299014 0.77 CYP1A2 (0.77) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL1347141 0.76 ALDH1A1 (0.48) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL27924015 0.76 CYP1A2 (0.56) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL3316584 0.75 CYP1A2 (0.61) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL3319487 0.75 CYP1A2 (0.55) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL1350517 0.74 KMT2A (0.52) CYP1A2CYP2D6CYP2C19TDP1KMT2A
SCHEMBL697409 0.74 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL697649 0.74 CYP1A2 (0.54) CYP1A2CYP2D6CYP2C19LMNATDP1
SCHEMBL23204988 0.74 L3MBTL1 (0.60) CYP1A2CYP2D6CYP2C19LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063090-B2 Mineralocorticoid receptor modulators MERCK SHARP & DOHME CORP. (US) 2011-11-22 US claimed
US-20100069452-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2010-03-18 US claimed
US-8063090-B2 Mineralocorticoid receptor modulators MERCK SHARP & DOHME CORP. (US) 2011-11-22 US disclosed
US-8063090-B2 Mineralocorticoid receptor modulators MERCK SHARP & DOHME CORP. (US) 2011-11-22 US disclosed
US-8063090-B2 Mineralocorticoid receptor modulators MERCK SHARP & DOHME CORP. (US) 2011-11-22 US disclosed
US-20100069452-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2010-03-18 US disclosed
US-20100069452-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2010-03-18 US disclosed
US-20100069452-A1 MINERALOCORTICOID RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2010-03-18 US disclosed
WO-2008118319-A2 MINERALOCORTICOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069452-A1 MINERALOCORTICOID RECEPTOR MODULATORS NR3C2, MC2R, NR3C1 CYP1A2 564/4885CYP2D6 391/4885CYP2C19 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.